Market Access & HEOR
Consultancy, analytics & evidence to optimise product value & uptake
Whether you have an asset in early pipeline, critical decisions to make about trial design, or an established brand approaching loss of exclusivity, we can guide you.
Operating from multiple global hubs, we support pharma, biotech and MD&D clients across the spectrum of market access & HEOR needs – working collaboratively to plan evidence generation, maximise access, and enhance the perception of value amongst critical access stakeholders.
Our Market Access & HEOR Solutions 
Why Ipsos for Market Access & HEOR?
- A fully integrated consultancy practice within Ipsos’ global healthcare business
- An international team of experts based in North America, Europe and Asia Pacific
- Extensive experience drawn from payer, industry and consulting backgrounds
- Access to payer stakeholders in all key markets
- Additional specialist expertise in advanced analytics, behavioural science, digital health & more
Recent thought leadership
Report: 30 Future Challenges In Evidence, Pricing & Access & How To Overcome Them
Paper: The Power Of Holistic Insights In Oncology
ISPOR VOS Article: What Will The Legislative Proposal For Joint Work On European HTA Approach Mean For Access In Europe?
Talk to us about optimising your market access strategy today.
